Clicky

Depression

Laughing gas has shown potential as a treatment for depression

By Clare Wilson Nitrous oxide, or laughing gas, is a common anaesthetic AMELIE-BENOIST/BSIPl/Alamy Nitrous oxide, also known as laughing gas, has shown promise as a treatment for depression. When people inhaled a low dose as part of a small study, their depression improved over the next two weeks. It has long been known that nitrous […]

Laughing gas has shown potential as a treatment for depression Read More »

Study finds breathing in laughing gas can help reduce depression symptoms

A new study by researchers at the University of Chicago and Washington University in St. Louis found that the effects of inhaling nitrous oxide gas, which is better known as laughing gas, can help reduce the symptoms of depression. The study was published Wednesday in Science Translational Medicine. According to the study, researchers found that

Study finds breathing in laughing gas can help reduce depression symptoms Read More »

Transcript: Concerns for Patients with Major Depressive Disorder and Insomnia Symptoms

Read the transcript: Dr. McCall:  Hi. I’m Vaughn McCall. I am the Case‑Distinguished Chair of Psychiatry for the Medical College of Georgia and the Executive Vice‑Dean for MCG. My clinical and research interests revolve around the intersection between sleep problems and mood disorders. Q:  What were the key takeaways from your recent session at the

Transcript: Concerns for Patients with Major Depressive Disorder and Insomnia Symptoms Read More »

Dartmouth College researchers report students are feeling more anxious and depressed than ever

First-year student Beau DuBray died by suicide in November, the campus newspaper, the Dartmouth, reported. Another freshman, Connor Tiffany, died “unexpectedly” in March, school officials said. Elizabeth Reimer, also a freshman, died in May at her home in Holtsville, N.Y., according to officials.

Dartmouth College researchers report students are feeling more anxious and depressed than ever Read More »

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs

VANCOUVER, BC, June 10, 2021 /PRNewswire/ – MYND Life Sciences Inc. (CSE: MYND) (“MYND“) a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce it has filed additional provisional patents that utilize various psilocybin analogs to target clinical depression. MYND Logo (CNW Group/Mynd Life Sciences

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs Read More »

Vitamin D levels associated with depressive symptoms

Whilst there have been some inconsistent results from previous studies, meta-analyses​ and systematic reviews​ indicate that depression may be related to low serum vitamin D concentrations. Previous studies have also indicated an association between depressive symptoms and low-grade inflammatory response​ while a decrease in pro-inflammatory markers has been observed after treatment with anti-depressants and it has been reported​

Vitamin D levels associated with depressive symptoms Read More »

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs

VANCOUVER, BC, June 10, 2021 /PRNewswire/ – MYND Life Sciences Inc. (CSE: MYND) (“MYND“) a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce it has filed additional  provisional patents that utilize various psilocybin analogs to target clinical depression. Major Depressive Disorder (“MDD”) is a common and severe illness

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs Read More »